New research in the Journal of Clinical Investigation suggests that blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia (AML). Researchers from Cincinnati Children’s Hospital Medical Center report their results in a study posted online Aug. 27 by the journal.
Hey, check out all the research scientist jobs. Post your resume today!
